CBST » Topics » Press Release

This excerpt taken from the CBST 10-Q filed May 1, 2009.

Press Release

 

 

 

Contacts:

 

 

Cubist Pharmaceuticals, Inc.

 

Alnylam Pharmaceuticals, Inc.

Eileen C. McIntyre

 

Cynthia Clayton (Investors)

781-860-8533

 

617-551-8207

eileen.mcintyre@cubist.com

 

 

 

 

 

Tara Murphy

 

Adriana Jenkins (Media)

Weber Shandwick

 

Yates Public Relations

617-520-7045

 

617-744-1713

TMurphy@WeberShandwick.com

 

 

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki